Literature DB >> 20635935

Multimodality treatment warranted for ovarian cancer: immunotherapy, a prerequisite to improve prognosis for this vicious disease.

Ninke Leffers, Toos Daemen, Ate G J van der Zee, Hans W Nijman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20635935     DOI： 10.2217/1750743X.1.2.163

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  2 in total

Review 1.  Antigen-specific active immunotherapy for ovarian cancer.

Authors:  Sterre T Paijens; Ninke Leffers; Toos Daemen; Wijnand Helfrich; H Marike Boezen; Ben J Cohlen; Cornelis Jm Melief; Marco de Bruyn; Hans W Nijman
Journal:  Cochrane Database Syst Rev       Date:  2018-09-10

2.  Retrospective quality of life study in patients with retroperitoneal sarcoma in an Asian population.

Authors:  Hui Jun Lim; Chin-Ann Johnny Ong; Thakshayeni Skanthakumar; Lisa Yuen Hong Mak; Seettha Devi Wasudevan; Joey Wee-Shan Tan; Claramae Shulyn Chia; Grace Hwei Ching Tan; Melissa Ching Ching Teo
Journal:  Health Qual Life Outcomes       Date:  2020-08-06       Impact factor: 3.077
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.